(Bloomberg) -- Merck & Co. forecast 2026 sales and profit that missed Wall Street’s expectations and said its HPV vaccine Gardasil may remain off the market in China this year as it continues to face ...
The appeal challenges U.S. District Judge Kenneth Bell’s summary judgment order concluding that implied federal preemption barred failure-to-warn claims in the Gardasil multidistrict litigation in the ...
Merck expects to lose $200 million to already-announced tariffs in 2025 amid a roiling trade war between the US and China. The company's first-quarter results beat estimates, with sales of $15.5 ...
Facing vaccine pressures in multiple markets, Merck & Co. is pruning the ranks at one of its key U.S. production facilities. In a Worker Adjustment and Retraining Notification (WARN) Act alert filed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results